Dall’11 al 15 Novembre 2018 si è tenuto in Messico, nella città di Mazatlán (Sin.), il 68° Congreso Mexicano de Obstetricia y Ginecología, ideato e organizzato dalla FEMECOG, Federación Mexicana de Colegios de Obstetricia y Ginecología, che dal 1960 si occupa costantemente della salute della donna attraverso la ricerca il confronto sui progressi medici in …More
Un figlio che non arriva… Una gravidanza impossibile… La disperata ricerca di restare incinta e la scoperta di essere sterile: un fantasma che segue come un’ombra Diana, la protagonista del romanzo. Claudio, il compagno sensibile e attento che l’aiuterà ad uscire dal baratro della depressione in cui la mancata maternità l’ha gettata e la convincerà …More
Il Prof. Vittorio Unfer, intervenuto alla trasmissione “Le Ali della Salute”, parla dell’inositolo nel trattamento della PCOS.
L’inositolo nella PCOS
Nella pratica clinica ostetrico-ginecologica, l’inositolo viene utilizzato nella policistosi ovarica e, in ostetricia, nella prevenzione del diabete gestazionale.
In realtà di policistosi ovarica non si guarisce, ma la sua sintomatologia si trasforma in menopausa, tra i 48 …More
Myo-inositol is a six carbon cyclitol that contains five equatorial and one axial hydroxyl groups. Myo-inositol has been classified as an insulin sensitizing agent and it is commonly used in the treatment of the Polycystic Ovary Syndrome (PCOS). However, despite its wide clinical use, there is still scarce information on the myo-inositol safety …More
In polycystic ovary syndrome (PCOS) pathogenesis, both the insulin resistance and the related compensatory hyperinsulinemia are involved. Despite their similarities, Myo-inositol (MI) and D-chiro-inositol (DCI) play different roles in PCOS etiology and therapy. Indeed, in tissue such as the liver both molecules are involved in the insulin signaling, i.e. MI promotes glucose uptake …More
PCOS is one of the most common endocrine disorders affecting women and it is characterized by a combination of hyper-androgenism, chronic anovulation, and insulin resistance. While a significant progress has recently been made in the diagnosis for PCOS, the optimal infertility treatment remains to be determined. Two inositol isomers, myo-inositol (MI) and D-chiro-inositol …More
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders affecting women of reproductive age. It is characterized by chronic anovulation, hyperandrogenism, and insulin resistance. It is the main cause of infertility due to the menstrual dysfunction and metabolic disorders. Women with PCOS also have an increased cardiovascular risk because of dyslipidemia and …More
We report an uncommon case of a 38-years-old pregnant woman affected by HHT (Hereditary haemorrhagic telangiectasia; OslerWeber-Rendu syndrome) who underwent to a caesarean section (CS) without any complication. The patient at 36th weeks+1 day pregnancy referred to the Emergency Obstetric Unit due to a intercostals pain on left side. On third day after …More
Objective: Neural tube defects (NTDs) are classified as folate sensitive (about 70%) and folate resistant (about 30%); although folic acid is able to prevent the former, several data have shown that inositol may prevent the latter. It has recently been proposed that coffee intake might represent a risk factor for NTD, likely by …More
Objective: Dose-dependent side effects related to myo-inositol (MI) oral administration represent a significant shortcoming for its clinical use. Aiming to search for a pharmaceutical form able to be better absorbed, the pharmacokinetic (PK) profile of the new manufactured MI soft gelatin capsule form was evaluated and compared with the commercially available MI powder.
Research design and methods: A …